Compare CLH & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CLH | QGEN |
|---|---|---|
| Founded | 1980 | 1986 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Environmental Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.1B | 10.2B |
| IPO Year | 1994 | 1998 |
| Metric | CLH | QGEN |
|---|---|---|
| Price | $288.95 | $40.58 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 9 |
| Target Price | ★ $290.82 | $51.30 |
| AVG Volume (30 Days) | 532.8K | ★ 1.8M |
| Earning Date | 05-21-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 5.86% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 7.28 | N/A |
| Revenue | ★ $2,944,978,000.00 | N/A |
| Revenue This Year | $4.18 | $8.23 |
| Revenue Next Year | $4.49 | $5.70 |
| P/E Ratio | $39.86 | ★ $24.01 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $178.29 | $38.13 |
| 52 Week High | $298.12 | $57.82 |
| Indicator | CLH | QGEN |
|---|---|---|
| Relative Strength Index (RSI) | 59.75 | 19.14 |
| Support Level | $225.18 | N/A |
| Resistance Level | $298.12 | $49.11 |
| Average True Range (ATR) | 7.42 | 1.03 |
| MACD | -1.28 | -0.79 |
| Stochastic Oscillator | 53.16 | 3.36 |
Clean Harbors Inc is an environmental and industrial services provider that provides parts cleaning and related environmental services to commercial, industrial, and automotive customers. Its business segments are Environmental Services and Safety-Kleen Sustainability Solutions. Environmental Services includes waste collection, transportation, treatment, recycling, and disposal, along with industrial maintenance services. Safety-Kleen Sustainability Solutions provides used oil collection and manufactures base oil, vacuum gas oil, and lubricants. The company generates the majority of its revenues from the Environmental Services segment and operates in the United States, with maximum revenue, and Canada.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).